| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Drug Development Research (Q2) | ||
| Dergi ISSN | 0272-4391 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 05-2022 |
| Cilt / Sayı / Sayfa | 83 / 3 / 586–604 | DOI | 10.1002/ddr.21887 |
| Makale Linki | http://dx.doi.org/10.1002/ddr.21887 | ||
| UAK Araştırma Alanları |
Organik Kimya
Spektroskopi
Biyokimya
|
||
| Özet |
| A series of novel sulfonates containing quinazolin‐4(3H)‐one ring derivatives was designed to inhibit aldose reductase (ALR2, EC 1.1.1.21). Novel quinazolinone derivatives (1–21) were synthesized from the reaction of sulfonated aldehydes with 3‐amino‐2‐alkylquinazolin‐4(3H)‐ones in glacial acetic acid with good yields (85%–94%). The structures of the novel molecules were characterized using IR, 1H‐NMR, 13C‐NMR, and HRMS. All the novel quinazolinones (1–21) demonstrated nanomolar levels of inhibitory activity against ALR2 (KIs are in the range of 101.50–2066.00 nM). Besides, 4‐[(2‐isopropyl‐4‐oxoquinazolin‐3[4H]‐ylimino)methyl]phenyl benzenesulfonate (15) showed higher inhibitor activity inhibited ALR2 up to 7.7‐fold compared to epalrestat, a standard inhibitor. Binding interactions between ALR2 and quinazolinones have been investigated using Schrödinger Small‐Molecule Drug … |
| Anahtar Kelimeler |
| ADME-Tox | aldose reductase | epalrestat | in silico study | molecular docking | quinazolinones |
| Atıf Sayıları | |
| Web of Science | 93 |
| Scopus | 89 |
| Google Scholar | 97 |
| Dergi Adı | DRUG DEVELOPMENT RESEARCH |
| Yayıncı | John Wiley & Sons Inc. |
| Açık Erişim | Hayır |
| ISSN | 0272-4391 |
| E-ISSN | 1098-2299 |
| CiteScore | 6,4 |
| SJR | 0,672 |
| SNIP | 0,722 |